Clinical Trials · NCT03800875

Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting

CompletedPhase 2Pramlintide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
McGill University
Enrollment
24
Start date
Feb 2019
Locations
1 site, Canada
Primary endpoint
Total percentage of time (22:00-22:00) that the glucose concentration remained within 3.9 and 10.0 mmol/L
View Pramlintide compound reference